Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mutagenesis | 1 | 2022 | 1263 | 0.320 |
Why?
|
Ovarian Neoplasms | 5 | 2022 | 4823 | 0.290 |
Why?
|
Mutation | 9 | 2024 | 29717 | 0.260 |
Why?
|
Nuclear Physics | 2 | 2014 | 79 | 0.240 |
Why?
|
Autistic Disorder | 1 | 2022 | 1174 | 0.220 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2024 | 241 | 0.200 |
Why?
|
Gene Amplification | 2 | 2023 | 1062 | 0.200 |
Why?
|
Music | 1 | 2024 | 259 | 0.190 |
Why?
|
Oncogenes | 2 | 2023 | 1263 | 0.180 |
Why?
|
Single-Cell Analysis | 4 | 2023 | 2183 | 0.180 |
Why?
|
Organ Specificity | 2 | 2023 | 2003 | 0.180 |
Why?
|
Neoplasms | 4 | 2024 | 21596 | 0.170 |
Why?
|
Leiomyosarcoma | 1 | 2023 | 477 | 0.170 |
Why?
|
Estrogen Receptor alpha | 1 | 2023 | 577 | 0.170 |
Why?
|
Platinum Compounds | 1 | 2019 | 96 | 0.160 |
Why?
|
BRCA1 Protein | 2 | 2022 | 1145 | 0.150 |
Why?
|
Translocation, Genetic | 1 | 2023 | 1417 | 0.150 |
Why?
|
Deoxycytidine | 1 | 2021 | 824 | 0.150 |
Why?
|
Point Mutation | 1 | 2022 | 1624 | 0.150 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 424 | 0.140 |
Why?
|
Likelihood Functions | 1 | 2019 | 1003 | 0.130 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 617 | 0.130 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1707 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3585 | 0.130 |
Why?
|
Genes, BRCA1 | 1 | 2019 | 780 | 0.130 |
Why?
|
DNA Replication | 1 | 2021 | 1397 | 0.120 |
Why?
|
Elementary Particles | 1 | 2014 | 55 | 0.120 |
Why?
|
Neutrons | 1 | 2014 | 76 | 0.120 |
Why?
|
DNA, Neoplasm | 1 | 2019 | 1758 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1683 | 0.110 |
Why?
|
Aging | 1 | 2022 | 8626 | 0.110 |
Why?
|
Transcription Factors | 1 | 2022 | 12164 | 0.110 |
Why?
|
INDEL Mutation | 2 | 2024 | 279 | 0.100 |
Why?
|
Models, Theoretical | 2 | 2014 | 3584 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2948 | 0.090 |
Why?
|
Prefrontal Cortex | 1 | 2021 | 2146 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11472 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2019 | 1351 | 0.090 |
Why?
|
Genome, Human | 4 | 2023 | 4420 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8425 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5163 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 1 | 2022 | 1337 | 0.070 |
Why?
|
Brain | 1 | 2022 | 26343 | 0.070 |
Why?
|
Computer Simulation | 1 | 2019 | 6191 | 0.070 |
Why?
|
Melanoma | 1 | 2023 | 5462 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12242 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5522 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6754 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2023 | 20774 | 0.060 |
Why?
|
Brain Neoplasms | 1 | 2024 | 8829 | 0.050 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16665 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9274 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9185 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 97 | 0.050 |
Why?
|
Humans | 17 | 2024 | 742088 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4187 | 0.050 |
Why?
|
Isoxazoles | 1 | 2021 | 216 | 0.050 |
Why?
|
Protein Binding | 1 | 2022 | 9387 | 0.040 |
Why?
|
Nucleotides | 1 | 2022 | 463 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2023 | 589 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13853 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 287 | 0.040 |
Why?
|
BRCA2 Protein | 1 | 2022 | 790 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2022 | 15494 | 0.040 |
Why?
|
Doxorubicin | 1 | 2023 | 2215 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2023 | 2713 | 0.040 |
Why?
|
Genomic Instability | 1 | 2021 | 695 | 0.040 |
Why?
|
Female | 8 | 2023 | 379592 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 704 | 0.030 |
Why?
|
Estrogens | 1 | 2023 | 1562 | 0.030 |
Why?
|
Embryonic Development | 1 | 2021 | 704 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2011 | 0.030 |
Why?
|
Pyrazines | 1 | 2021 | 1231 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 981 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2431 | 0.030 |
Why?
|
DNA Repair | 1 | 2023 | 2042 | 0.030 |
Why?
|
Gene Frequency | 1 | 2021 | 3587 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 12071 | 0.030 |
Why?
|
DNA Damage | 1 | 2023 | 2423 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 956 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2021 | 4742 | 0.030 |
Why?
|
Cell Division | 1 | 2021 | 4564 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 1940 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1786 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6313 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 594 | 0.030 |
Why?
|
Heterozygote | 1 | 2019 | 2790 | 0.030 |
Why?
|
Piperidines | 1 | 2020 | 1602 | 0.030 |
Why?
|
Alleles | 1 | 2021 | 6931 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7289 | 0.020 |
Why?
|
Software | 1 | 2023 | 4434 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3518 | 0.020 |
Why?
|
Chromatin | 1 | 2021 | 2917 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3564 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4801 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3639 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9410 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4438 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14554 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19862 | 0.020 |
Why?
|
Mice | 2 | 2023 | 81045 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5655 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10472 | 0.020 |
Why?
|
Apoptosis | 1 | 2021 | 9715 | 0.020 |
Why?
|
Neurons | 1 | 2022 | 9325 | 0.010 |
Why?
|
Animals | 2 | 2023 | 168561 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17400 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29087 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53187 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40450 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57683 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 62966 | 0.010 |
Why?
|
Aged | 1 | 2020 | 162944 | 0.000 |
Why?
|
Male | 1 | 2024 | 349538 | 0.000 |
Why?
|
Middle Aged | 1 | 2020 | 213127 | 0.000 |
Why?
|
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(74)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_